A partnership between UC Davis and Maurice J. Gallagher Jr., chairman and CEO of Allegiant Travel Company, has led to a new rapid COVID-19 test. A recent study published Nature Scientific Reports shows the novel method to be 98.3 percent accurate for positive COVID-19 tests and 96 percent accurate for negative tests. “This test was made from […]

The Agreement Aims to Accelerate the Continuum of Diagnostic Biomarker Discovery through to Assay Development and Clinical Testing SCHLIEREN, (Zurich, Switzerland) – Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announces today that it has established a strategic agreement with Siemens Healthineers, a global medical technology company, through its clinical laboratory in […]

Together, CDS and SAT are leveraging the latest mobile and wearable technologies to achieve remote, longitudinal tracking of biomarkers in clinical trials RENO, Nev. — Crucial Data Solutions, Inc. (CDS), a provider of innovative software to advance clinical research, and SISCAPA Assay Technologies, Inc. (SAT), a biotechnology company focused on understanding longitudinal changes in health […]

Newomics Inc., a biotechnology company developing and commercializing mass spectrometry solutions, today announced that it has established a North America Sales Team, and it is launching a new product to enhance the existing mass spectrometry workflows. Newomics continues its dedication to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. […]

FRAMINGHAM, Mass. — SCIEX, a global leader in life science analytical technologies, announced Joe Fox as President, effective April 1, 2021. Mr. Fox assumes the role from Inese Lowenstein, who led SCIEX for four years. Ms. Lowenstein has been appointed Senior Talent Advisor at Danaher, responsible for new President coaching, DBS immersion tool development and advising on […]

Seer Proteograph™ Product Suite combined with SCIEX mass spectrometry technology to provide unbiased, deep proteomics workflows for labs of all types REDWOOD CITY, Calif. — Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that they have signed a non-exclusive commercial agreement with SCIEX, a global leader in […]

ROCHESTER, Minn. ― Mayo Clinic and Thermo Fisher Scientific have joined forces to bring innovative solutions to patients by accelerating clinical validation, and commercialization of selected next-generation sequencing (NGS), mass spectrometry and immunology diagnostic tools. The Advanced Diagnostics Laboratory in One Discovery Square, which is part of the Destination Medical Center initiative, will be the home […]

Protein Metrics’ software solutions complement Thermo Fisher’s mass spectrometry systems to facilitate precise, reliable data processing and drive innovation GERMERING, Germany – Thermo Fisher Scientific, the world leader in serving science, and Protein Metrics, a developer of world-class software tools for protein characterization, have entered into a non-exclusive co-marketing agreement to provide advanced mass spectrometry data processing […]

New End-to-End Compliant-Ready Workflow Helps Biotherapeutic Protein Manufacturers Meet Regulatory and Attribute-Based Product Analysis Requirements for Drug Identity, Purity, and Quality NEWS SUMMARY: New Peptide MAM (multi-attribute method) workflow for the BioAccord LC-MS System monitors product quality attributes that can affect efficacy and safety of innovator drugs and biosimilars. End-to-end streamlined LC-MS workflow for analyzing […]

Roman Fischer of Oxford University demonstrates high-throughput 4D proteomicson non-depleted, untreated plasma identifying >350 protein groups with short 10-20 minute methods, enabling high throughput, robust biomarker discovery OmicEra Diagnostics reports running 720 undepleted serum samples from 31 COVID-19 patients over just 12 days on a single timsTOF Pro system at a rate of 60 samples/day, […]